Steel Grove Capital Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,445
Closed -$210K 181
2024
Q4
$210K Sell
2,445
-1,540
-39% -$132K 0.03% 170
2024
Q3
$481K Buy
3,985
+195
+5% +$23.5K 0.07% 120
2024
Q2
$541K Buy
3,790
+86
+2% +$12.3K 0.07% 112
2024
Q1
$476K Buy
3,704
+1,200
+48% +$154K 0.06% 128
2023
Q4
$259K Sell
2,504
-108
-4% -$11.2K 0.04% 157
2023
Q3
$238K Buy
2,612
+48
+2% +$4.37K 0.03% 162
2023
Q2
$207K Buy
+2,564
New +$207K 0.03% 179
2019
Q1
Sell
-22,768
Closed -$524K 226
2018
Q4
$524K Sell
22,768
-832
-4% -$19.1K 0.07% 189
2018
Q3
$556K Buy
23,600
+1,246
+6% +$29.4K 0.08% 193
2018
Q2
$515K Buy
22,354
+2,432
+12% +$56K 0.08% 188
2018
Q1
$498K Buy
19,922
+11,132
+127% +$278K 0.08% 210
2017
Q4
$236K Buy
+8,790
New +$236K 0.04% 266